|
|
Makerere University Research Repository >
College of Health Sciences >
School of Health Sciences >
Research Articles (Health-Sciences) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/1757
|
| Title: | The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda |
| Authors: | Ocama, Ponsiano
Katwere, Michael
Piloya, Theresa
Feld, Jordan
Opio, Kenneth C.
Katabira, Elly
Thomas, David
Colebunders, Robert
Ronald, Allan |
| Keywords: | Liver disease
HIV/AIDS
Hepatitis B
Hepatitis C
Antiretroviral therapy
Uganda |
| Issue Date: | 2008 |
| Publisher: | Makerere University Medical School |
| Citation: | Ocama, P., Katwere, M., Piloya, T., Feld, J., Opio, K.C., Katabira, E., Thomas, D., Colebunders, R., Ronald, A. (2008). The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. African Health Sciences, 8(1) |
| Abstract: | Background: Liver diseases are common in patients with HIV due to viral hepatitis B and C co-infections, opportunistic infections or
malignancies, antiretroviral drugs and drugs for opportunistic infections.
Objective: To describe the spectrum of liver diseases in HIV-infected patients attending an HIV clinic in Kampala, Uganda.
Method: Consecutive patients presenting with jaundice, right upper quadrant pain with fever or malaise, ascites and/or tender
hepatomegaly were recruited and underwent investigations to evaluate the cause of their liver disease.
Results: Seventy-seven consecutive patients were recruited over an eleven month period. Of these, 23 (30%) had increased transaminases
because of nevirapine (NVP) and/or isoniazid (INH) hepatotoxicity. Although 14 (61%) patients with drug-induced liver disease
presented with jaundice, all recovered with drug discontinuation. Hepatitis B surface antigen was positive in 11 (15%) patients while
anti-hepatitis C antibody was reactive in only 2 (3%). Probable granulomatous hepatitis due to tuberculosis was diagnosed in 7 (9%)
patients and all responded to anti-TB therapy. Other diagnoses included alcoholic liver disease, AIDS cholangiopathy, hepatocellular
carcinoma, schistosomiasis, haemangioma and hepatic adenoma. Twelve (16%) patients died during follow-up of which 7 (9%) died
because of liver disease.
Conclusion: Drug history, liver enzyme studies, ultrasound, and hepatitis B and C investigations identified the probable etiology in 60
(78%) of 77 patients with HIV infection presenting with symptoms and/or signs of liver disease. |
| URI: | http://hdl.handle.net/123456789/1757 |
| ISSN: | 1680-6905 |
| Appears in Collections: | Research Articles (Health-Sciences)
|
Files in This Item:
| File |
Description |
Size | Format |
|---|
| Ocama-chs-res.pdf | | 118Kb | Adobe PDF | View/Open |
|
All items in DSpace are protected by copyright, with all rights reserved.
|
